At the Human Amyloid Imaging (HAI) meeting, held January 15-17, researchers focused on new techniques—all based on tau and blood, conference title notwithstanding—for identifying whether a person has ...

为了深入探究这些问题，来自中日友好医院、首都医科大学宣武医院等多家单位的研究人员，在《Alzheimer's Research & Therapy》期刊上发表了一篇名为 “Investigating the Aβ and tau pathology in autosomal dominant Alzheimer’s disease: insights from hybrid PET/MRI and ...

In vivo imaging of tau pathology by PET will allow new insights into tau deposition in the human brain, facilitating research into causes, diagnosis and treatment of major neurodegenerative ...

By quantifying the amount of tau in the brain tissue with PET imaging, physicians can appropriately stage Alzheimer's disease in patients and determine the best treatment options. "Identifying tau ...

Study uses PET imaging and cerebrospinal fluid proteomics to identify 127 distinct proteins linked to Alzheimer’s disease, highlighting unique molecular signatures and potential therapeutic targets.

Tau silencing gene therapy VY1706 robustly reduced tau mRNA levels, with broad distribution, and was well-tolerated in NHP study; IND filing ...

Following this, the company has begun a multiple ascending dose (MAD) trial in patients with early Alzheimer's disease, with initial tau PET imaging data expected in the second half of 2026.

The biomarker findings also aligned with Braak NFT stages based on tau-PET imaging. This study demonstrates that pre-NFT tau assemblies in AD have distinct biochemical properties compared to those ...

PET imaging is improved by employing edaravone to track oxidative stress, allowing for earlier detection of neurodegenerative ...

initial tau PET imaging data in Alzheimer’s patients expected H2 2026 - LEXINGTON, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company ...

One exam, a tau PET scan, relies on a radioactive tracer ... detect early stages of tau pathology and it requires specialized imaging centers. Other tests measure the level of amyloid beta ...